pharmaphorum

MARCH 19, 2021

The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The webinar will also cover: How HCP engagement changed for pharma in 2020. How engagement with HCPs will evolve in the future.

Compounding 141

Compounding Pharmaceutical Companies Pharmaceutical Companies Communication 141

Pharma Marketing Network

JULY 27, 2023

Developing strong and meaningful relationships with Healthcare Professionals (HCPs) is vital for healthcare organizations, pharmaceutical companies, and medical device manufacturers alike. These partnerships not only improve patient outcomes but also foster mutual trust and collaboration.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Patient Care 98

Viseven

AUGUST 15, 2024

In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? Why is Patient Engagement Important for Pharma? Prioritize customer support Customer support has emerged as a critical factor in patient engagement.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Packaging 52

pharmaphorum

MARCH 29, 2017

Pharmacists are highly trained healthcare professionals who have a deep understanding of medicines and daily contact with patients and consumers.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Patient Care 52

Viseven

MAY 15, 2023

Pharmaceutical detailing is the most time-tested marketing format in the medical content world. Old-timer sales reps should remember how pharmaceutical companies reckoned face-to-face (F2F) visits with doctors as the most effective approach to achieving their sales targets. What is Pharmaceutical Detailing?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Patient Care 52

Omnicell

SEPTEMBER 5, 2022

Medicaid lowered the cost of drugs reimbursed by state Medicaid agencies by requiring pharmaceutical companies to enter into a rebate agreement with the Secretary of the Department of Health and Human Services (HHS) as a precondition for coverage of their drugs by Medicaid as well as Medicare Part B. Add link to Omnicell's Webinars.

Omnicell 52

Omnicell Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 23, 2021

A recent pharmaphorum webinar on digital transformation , held in association with P360, explored how COVID has fast-tracked pharma’s long-held ambitions to make wider use of digital technology and streamline its communications with HCPs. “At Follow him on Twitter or connect with him on LinkedIn.

Communication 92

Communication Patient Care Compounding Pharmaceutical Companies 92